Aurinia Pharmaceuticals (AUPH)
(Delayed Data from NSDQ)
$5.03 USD
-0.06 (-1.18%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $5.03 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/2/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.19 |
Last EPS Surprise | -5.56% |
ABR | 1.71 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.06 |
Next Year | 0.55 |
EPS (TTM) | -0.54 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 46.30M | 54.19M | 225.59M | 302.21M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 47.79M | 56.31M | 232.81M | 339.89M |
Low Estimate | 44.80M | 51.53M | 216.70M | 270.40M |
Year ago Sales | 34.41M | 41.49M | 175.51M | 225.59M |
Year over Year Growth Est. | 34.55% | 30.60% | 28.53% | 33.97% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.02 | -0.06 | 0.55 |
# of Estimates | 3 | 3 | 5 | 4 |
Most Recent Consensus | -0.17 | 0.04 | 0.09 | 0.95 |
High Estimate | -0.13 | 0.04 | 0.15 | 0.95 |
Low Estimate | -0.20 | -0.06 | -0.34 | 0.18 |
Year ago EPS | -0.18 | -0.08 | -0.54 | -0.06 |
Year over Year Growth Est. | 5.56% | 75.00% | 88.89% | 1,019.17% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.02 | -0.06 | 0.55 |
7 Days Ago | -0.17 | -0.02 | -0.06 | 0.55 |
30 Days Ago | -0.17 | -0.02 | -0.06 | 0.55 |
60 Days Ago | -0.16 | -0.02 | -0.06 | 0.53 |
90 Days Ago | -0.11 | -0.03 | -0.27 | 0.05 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.17 | -0.02 | -0.06 | 0.55 |
Zacks Consensus Estimate | -0.17 | -0.02 | -0.06 | 0.55 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.19 | -0.09 | -0.08 | -0.18 | NA |
Estimate | -0.18 | -0.17 | -0.20 | -0.24 | NA |
Difference | -0.01 | 0.08 | 0.12 | 0.06 | 0.06 |
Surprise | -5.56% | 47.06% | 60.00% | 25.00% | 31.63% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more